Laboratory Animal and Comparative Medicine ›› 2026, Vol. 46 ›› Issue (5): 629-639.DOI: 10.12300/j.issn.1674-5817.2025.212

• Laboratory Animals for Traditional Chinese Medicine Research • Previous Articles     Next Articles

Study on the Mechanism of Gegen Qinlian Decoction in Improving Diabetic Myocardial Injury

JIANG Miaomiao1,2, FANG Jinping2, HUANG Zongxuan2, LI Jiamin3, LIAO Huan1,2, ZHANG Wenqiang1,2, YU Jiaying2, YANG Yanyan4, LIAN Dawei1,2()()   

  1. 1. Academy of Integrative Medicine, Fujian University of Traditional Chinese Medicine, Fuzhou 350122, China
    2. College of Integrative Medicine, Fujian University of Traditional Chinese Medicine, Fuzhou 350122, China
    3. College of Pharmacy, Fujian University of Traditional Chinese Medicine, Fuzhou 350122, China
    4. Innovation and Transformation Center, Fujian University of Traditional Chinese Medicine, Fuzhou 350122, China
  • Received:2025-12-17 Revised:2026-02-26 Online:2026-10-25 Published:2026-10-16
  • Correspondence to: LIAN Dawei

Abstract:

Objective To explore the effect and mechanism of Gegen Qinlian decoction (GQD) on myocardial injury induced by high-fat diet combined with streptozotocin in type 2 diabetic mice through network pharmacology and animal experiments. Methods Network pharmacology was applied to screen the potential signaling pathways of GQD in the intervention of diabetic heart disease (DHD). A total of 36 specific pathogen-free (SPF) male C57BL/6J mice aged 8 weeks were acclimatized for 1 week and randomly divided into a normal control group (n=6) and a model group (n=30). Mice in the model group were fed a 60% high-fat diet and 5% glucose water for 4 weeks, and were intraperitoneally injected with 100 mg/kg streptozotocin after 12 h of fasting to establish the type 2 diabetes model. Mice in the normal control group were given a conventional diet and drinking water, and were intraperitoneally injected with an equal volume of citrate buffer after 12 h of fasting at the same time point. After successful establishment of the diabetic mouse model, the model mice were randomly divided into five groups according to body weight: model control group, GQD low-dose group, GQD medium-dose group, GQD high-dose group, and metformin positive control group, with 6 mice in each group. After 6 weeks of intragastric administration of corresponding doses of GQD, metformin, and ddH2O respectively, all mice in the six groups (one normal control group and five model groups) were anesthetized with inhaled 2% isoflurane, blood samples were collected via eyeball enucleation, and heart tissues were harvested after euthanasia by cardiac exsanguination. Hematoxylin-eosin (HE) staining and wheat germ agglutinin (WGA) staining were performed to observe the pathological damage of myocardial tissues and measure the cross-sectional area of cardiomyocytes. Enzyme-linked immunosorbent assay (ELISA) was used to measure the levels of pro-inflammatory cytokines in serum. Immunohistochemical staining was adopted to determine the protein expression levels of receptor for advanced glycation end products (RAGE), nucleotide-binding domain leucine-rich repeat and pyrin domain-containing receptor 3 (NLRP3), and phosphorylated nuclear factor-κB p65 (p-p65) in myocardial tissues. Results Network pharmacology analysis revealed that the targets of GQD against DHD were significantly enriched in inflammatory pathways, including the advanced glycation end products (AGEs)-RAGE axis, tumor necrosis factor (TNF) and interleukin-17 (IL-17) signaling pathways. HE and WGA staining results showed that, compared with the normal control group, the model control group exhibited myocardial fiber rupture, cardiomyocyte swelling, and significantly increased cardiomyocyte cross-sectional area (P<0.05). Compared with the model control group, GQD intervention significantly ameliorated the pathological changes, including myocardial fiber rupture, cell swelling, and cardiomyocyte hypertrophy. The results of immunohistochemical staining and ELISA indicated that compared with the model control group, GQD intervention markedly downregulated the protein expression of RAGE, NLRP3, and p-p65 in myocardial tissues, as well as the levels of serum pro-inflammatory cytokines (P<0.05). Conclusion GQD can effectively alleviate myocardial pathological injury in diet-induced type 2 diabetic mice, and its mechanism may be related to inhibiting the activation of the RAGE/p-p65/NLRP3 signaling pathway and reducing myocardial inflammatory response.

Key words: Gegen Qinlian decoction, Diabetic myocardial injury, Inflammation, C57BL/6J mice

CLC Number: